Hello Heart Hero
www.cdc.gov/diabetes/pdfs/ data/statistics/national-diabetes-statistics-report.pdf
In the last 6-8 years, groundbreaking studies have shown the huge benefits of these medications, including reducing dementia, heart disease, and 23 obesity-related cancers, and the list continues to grow
Role of GLP-1 Receptor Agonists for Weight Loss Key studies including the SCALE and STEP trials are highlighted and the efficacy of the GLP-1 receptor agonists liraglutide and
For 2025, there are no major status changes where a substance changes from permitted to prohibited or vice versa, but the 2025 Prohibited List does include new examples of prohibited substances and a few clarifications
8.1.4 The C65G tRNA [Ser]Sec mutation: A single-point mutation uncoupling selenoprotein expression from selenium availability Among the rare inborn errors directly affecting tRNA [Ser]Sec itself, a homozygous point mutation at position 65 of the acceptor arm (C65G